Drug type: Gefitinib is a targeted therapy. It is classified as a signal transduction inhibitor (epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor) - (For more detail, see "How this drug works," below.)
What this drug is used for:
For the treatment of locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.